|1.||Kang, Kui Dong: 2 articles (05/2010 - 07/2009)|
|2.||Ukil, Anindita: 1 article (09/2014)|
|3.||Biswas, Arunima: 1 article (09/2014)|
|4.||Das, Pijush K: 1 article (09/2014)|
|5.||Srivastav, Supriya: 1 article (09/2014)|
|6.||Saha, Amrita: 1 article (09/2014)|
|7.||Mukherjee, Madhuchhanda: 1 article (09/2014)|
|8.||Serra-Pages, Mariona: 1 article (12/2012)|
|9.||Rivera, Juan: 1 article (12/2012)|
|10.||Torres, Rosa: 1 article (12/2012)|
07/01/1994 - "Butaprost(EP2) induced hyperalgesia at doses higher than 50 ng kg-1.5. "
07/01/1994 - "Butaprost (EP2), 11-deoxy PGE1 (EP2 = EP3), MB 28767 (EP3), and cicaprost (prostaglandin I2 (IP-) receptor) induced allodynia, but with much lower scores. "
04/17/1995 - "Intrathecal injection of butaprost (10 ng/mouse), an EP2 agonist, induced hyperalgesia, and this hyperalgesia was blocked by D-AP5, 7-Cl-KynA, ketamine, and MK801, similar to that induced by 10 ng of PGE2. "
10/01/1997 - "6. PGE2, PGF2alpha, butaprost (an EP2 agonist) and cicaprost (a PGI receptor agonist) did not affect the nociceptin-induced allodynia. "
|2.||Ganglion Cysts (Ganglion)
01/01/2011 - "In IL-1β-treated osteoarthritis chondrocytes, butaprost suppressed MMP-13 production, which was further decreased by COX-2 inhibitor. "
01/01/2011 - "The authors performed further measurements of MMP-13 production in osteoarthritis chondrocytes stimulated by the EP2 agonist butaprost in the presence or absence of interleukin-1β (IL-1β) and/or cyclooxygenase-2 (COX-2) inhibitor. "
07/01/2009 - "Butaprost injected intravitreally significantly blunts the detrimental influence of ischemia/reperfusion to the retina."
07/01/2009 - "Most of these changes induced by ischemia/reperfusion were significantly blunted by butaprost. "
07/01/2009 - "Butaprost was injected intravitreally immediately after ischemia. "
07/01/2009 - "To localize different prostaglandin E(2) receptors in rat retinas of varying age, deduce how they are affected by acute stress insult, and determine whether the negative effect of ischemia/reperfusion is attenuated by the EP2 agonist butaprost. "
07/01/2009 - "Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia."
|3.||Prostaglandins E (PGE)
|5.||Cyclooxygenase 2 (Cyclooxygenase-2)
|6.||Prostaglandin E Receptors (Prostaglandin E Receptor)
|7.||Dizocilpine Maleate (Dizocilpine)